风险因素和预测得分对于氨酸诱导的皮肤反应
Chumpol Anamnart1, Ram Kitjarak2
1Division of Neurology, Department of Medicine, Prapokklao Hospital, 38 Leab Noen Rd, Tumbon Wat Mai, Mueang District, Chanthaburi City, 22000, Thailand. chumpolan@gmail.com.
概括
这项研究确定了氨酸诱导的皮肤不良药物反应 (CADRs) 的关键风险因素,并制定了预测得分. 该工具有助于临床医生识别需要密切监测这些严重皮肤反应的患者.
科学领域:
- 药物监督 药物监督 药物监督
- 临床风险评估临床风险评估
- 皮肤病学 皮肤病学
背景情况:
- 氨酸仍然是全球广泛使用的抗发作药物.
- 皮肤药物不良反应 (CADRs) 对氨酸是一个重要的临床问题,从轻微的皮疹到严重的疾病.
研究的目的:
- 为了确定因氨酸诱导的CADRs的临床风险因素.
- 在住院患者中开发和验证这些不良事件的临床预测得分.
主要方法:
- 这是一项对447名成人患者进行的回顾性队列研究,这些患者首次接受了氨酸.
- 后勤回归分析确定了独立的风险因素.
- 开发和评估了临床预测得分,使用接收器操作特征曲线 (AuROC) 下的区域进行评估.
主要成果:
- 10.5%的患者发生了CADR.
- 独立的危险因素包括恶性瘤,艾滋病毒感染,酒精依赖,同时使用西巴姆或卡巴.
- 预测得分显示出良好的预测能力 (AuROC=0.856).
结论:
- 开发了一种经过验证的临床预测评分,用于氨酸诱导的CADR.
- 该工具利用可访问的临床因素来识别高风险患者.
- 建议进行进一步的前性研究以进行外部验证并确认临床效用.
相关概念视频
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
275
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
275
Pharmacokinetics in Pediatric Patients: Drug Distribution
231
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
231
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
157
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
157
Pharmacokinetics: Drug–Drug Interactions
313
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
313


